Account-Based Marketing (ABM)HealthTechSeries Bintermediate

Account-Based Marketing for HealthTech at Series B

A step-by-step playbook for implementing account based marketing at a Series B-stage HealthTech company. This guide covers everything from initial setup and team requirements to execution, measurement, and optimization — tailored specifically for HealthTech companies with significant budget for scaling proven channels and dedicated growth team with functional specialists. Includes specific KPIs, recommended tools, common pitfalls to avoid, and expert insights from Ehsan Jahandarpour.

Timeline: 2-4 months

Prerequisites

✓ Established product with proven product-market fit
✓ Analytics infrastructure capturing key user events
✓ HIPAA, FDA, and healthcare-specific regulations require specialized compliance infrastructure — ensure compliance before scaling
✓ CRM with clean account data
✓ Sales team aligned on target account criteria

Step-by-Step Guide

Build your ideal customer profile (ICP)

Define your target accounts using firmographic data (industry, size, tech stack, funding) and behavioral signals (hiring patterns, content engagement). For HealthTech companies at the Series B stage, this step is particularly important given scaling what works and expanding to new segments.

Pro tip: Start with your best 10 current customers and reverse-engineer what they have in common. In the HealthTech context, also consider: HIPAA compliance complexity.

Build a target account list

Create a tiered list of target accounts: Tier 1 (10-25 accounts, fully personalized), Tier 2 (50-100, semi-personalized), Tier 3 (200-500, programmatic). For HealthTech companies at the Series B stage, this step is particularly important given scaling what works and expanding to new segments.

Pro tip: Use tools like ZoomInfo, Apollo, or LinkedIn Sales Navigator to enrich your list. In the HealthTech context, also consider: slow adoption by medical professionals.

Map buying committees

Identify 3-7 stakeholders per target account: economic buyer, champion, technical evaluator, end user, and blocker. Create personalized messaging for each role. For HealthTech companies at the Series B stage, this step is particularly important given scaling what works and expanding to new segments.

Pro tip: The champion is the most important person — they sell internally when you are not in the room. In the HealthTech context, also consider: long procurement cycles.

Create personalized content and ads

Develop account-specific landing pages, case studies, and ad creative. Use dynamic content to reference the target company name and industry challenges. For HealthTech companies at the Series B stage, this step is particularly important given scaling what works and expanding to new segments.

Pro tip: One deeply personalized email beats 100 generic ones. Mention specific company initiatives or challenges. In the HealthTech context, also consider: clinical validation requirements.

Orchestrate multi-channel outreach

Coordinate touchpoints across email, LinkedIn, display ads, direct mail, and events. Each touchpoint should build on the last. For HealthTech companies at the Series B stage, this step is particularly important given scaling what works and expanding to new segments.

Pro tip: Use a 21-day cadence: email day 1, LinkedIn day 3, ad impression day 5, follow-up email day 7. In the HealthTech context, also consider: HIPAA compliance complexity.

Expected Outcomes

✓ 40-60% engagement rate from target HealthTech accounts
✓ 2-3x higher deal size for ABM-targeted accounts
✓ 25-35% faster sales cycle for accounts with multi-threaded engagement
✓ ABM-influenced pipeline accounting for 30-50% of total pipeline

KPIs to Track

● ABM-influenced pipeline
● Account penetration rate
● Deal velocity for ABM accounts
● Win rate for ABM vs non-ABM

Common Mistakes to Avoid

⚠Running ABM without sales alignment

⚠Measuring ABM with demand gen metrics

⚠Giving up before the 6-month mark

Ehsan's Growth Commentary

HealthTech ABM is mandatory because the buyer universe is small and concentrated: there are ~6,000 hospitals in the US, and the top 200 health systems control 50%+ of beds. Every enterprise healthtech company is running ABM against the same 200 targets. The healthtech ABM differentiation: clinical evidence. While competitors send generic case studies, the most effective healthtech ABM delivers account-specific clinical projections. "Based on your hospital's patient volume and case mix, our AI would have flagged 47 additional cases last quarter that matched clinical trial criteria, representing $2.3M in potential trial revenue." This level of specificity requires analyzing publicly available hospital data (CMS quality reports, HCAHPS scores, case mix indices) and modeling your product's impact on that specific hospital. The effort is significant (2-4 hours per target account) but the conversion rate for account-specific clinical projections is 3-5x higher than generic ABM.

ABM is a team sport. If sales and marketing are not meeting weekly to review target account engagement, it is not ABM. In HealthTech, the buying committee typically has 5-7 stakeholders. Map all of them before your first outreach. Personalized direct mail still works. A $50 gift with a personal note outperforms $5,000 in digital ads for enterprise deals.

Ehsan Jahandarpour

AI Growth Strategist & Fractional CMO

Forbes Top 20 Growth Hacker · TEDx Speaker · 716 Academic Citations · Ex-Microsoft · CMO at FirstWave (ASX:FCT) · Forbes Communications Council

Frequently Asked Questions

How long does it take to see results from account based marketing in HealthTech?

For HealthTech companies at the Series B stage, expect to see early signals within 4-8 weeks and meaningful results within 3-6 months. The timeline depends on your current baseline, team capacity, and significant budget for scaling proven channels. Focus on leading indicators early and shift to lagging indicators (revenue, retention) over time.

What budget should a Series B HealthTech company allocate to account based marketing?

At the Series B stage with significant budget for scaling proven channels, allocate 10-20% of your growth budget to account based marketing. For HealthTech specifically, this means investing in Epic and Redox and dedicating at least one team member 50%+ of their time. Start small, prove ROI, then scale investment proportionally.

What are the biggest risks of account based marketing for HealthTech companies?

The primary risks are: (1) spreading too thin across tactics instead of going deep on one, (2) not adapting the approach to HealthTech-specific dynamics like HIPAA compliance complexity, (3) measuring vanity metrics instead of business outcomes, and (4) giving up before the tactic has time to compound. Mitigate these by setting clear success criteria and committing to a 90-day minimum test period.

Can account based marketing work alongside other growth strategies?

Absolutely — and it should. account based marketing is most powerful when combined with complementary tactics. For HealthTech at Series B, pair it with content marketing for top-of-funnel, and a strong activation flow for conversion. The key is to avoid diluting focus: master one tactic before adding another. Think of it as stacking growth loops, not running parallel experiments.

How do I measure the ROI of account based marketing in HealthTech?

Track both leading indicators (engagement, traffic, activation) and lagging indicators (pipeline, revenue, retention). For HealthTech companies, the most important metrics are CAC from this channel, conversion rate at each funnel stage, and LTV of customers acquired through account based marketing. Set up proper attribution using UTM parameters, cohort analysis, and ideally a multi-touch attribution model. Report ROI monthly to stakeholders.